{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-056146","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.346437+00:00","generated_at":"2026-06-03T01:32:02.938045+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Theriva Biologics amends ATM sales agreement with A.G.P., terminates B. Riley","bullets":["Entered Amendment No. 2 to At Market Issuance Sales Agreement with A.G.P./Alliance Global Partners on May 2, 2024.","Amendment updates registration statement to new Form S-3 filed May 2, 2024 for future at-the-market offerings.","B. Riley Securities, Inc. agreed to termination as party to the Sales Agreement effective May 1, 2024.","Other terms of the original agreement remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-056146","json":"https://secwatch.observer/filing/0001104659-24-056146.json","markdown":"https://secwatch.observer/filing/0001104659-24-056146.md","text":"https://secwatch.observer/filing/0001104659-24-056146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465924056146/0001104659-24-056146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465924056146/tm2413223d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T01:32:02.938045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}